Monges Viviane sold 9,667 shares of Pharvaris N.V. at $30.29 for −$293k on May 21, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed May 26, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$292,853.06Shares × reported price
Shares traded
9,667Common Stock
Price per share
$30.29Reported price. Read footnotes for ranges.
% of reported position traded
63.74%This security and ownership context
Holdings after
5,500Direct
Trade date
May 21, 2026Sell
Filed
May 26, 2026, 5:53 PM ET5-day reporting delay
Accession
0001193125-26-239754Code S · Transaction 384977
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 15,167 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

PHVS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PHVS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −2.4%1w ago +2.7%1d ago −1.4%
Returns since7d −3%30d +11%90d +25%180d1y

Footnotes in full

F1: The total number of shares beneficially owned previously reported in the Form 3 filed on March 18, 2026 was understated by 513 shares due to administrative errors in the number of shares reported as withheld for tax obligations in connection with RSU releases occurring on April 11, 2025 and March 12, 2026. This filing reflects the corrected beneficial ownership amount. F2: The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.08 to $30.49 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.